Aehr Test Systems Earnings Calls
| Release date | Jul 14, 2026 |
| EPS estimate | -$0.0100 |
| EPS actual | - |
| Revenue estimate | 18.686M |
| Revenue actual | - |
| Expected change | +/- 9.05% |
| Release date | Apr 07, 2026 |
| EPS estimate | -$0.0800 |
| EPS actual | -$0.0500 |
| EPS Surprise | 37.50% |
| Revenue estimate | 10.846M |
| Revenue actual | 10.3M |
| Revenue Surprise | -5.03% |
| Release date | Jan 08, 2026 |
| EPS estimate | -$0.0800 |
| EPS actual | -$0.0400 |
| EPS Surprise | 50.00% |
| Revenue estimate | 11.576M |
| Revenue actual | 9.9M |
| Revenue Surprise | -14.48% |
| Release date | Oct 06, 2025 |
| EPS estimate | $0.0100 |
| EPS actual | $0.0100 |
| Revenue estimate | 11.118M |
| Revenue actual | 10.969M |
| Revenue Surprise | -1.34% |
Last 4 Quarters for Aehr Test Systems
Below you can see how AEHR performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 06, 2025 |
| Price on release | $31.65 |
| EPS estimate | $0.0100 |
| EPS actual | $0.0100 |
| Date | Price |
|---|---|
| Sep 30, 2025 | $30.11 |
| Oct 01, 2025 | $33.25 |
| Oct 02, 2025 | $32.25 |
| Oct 03, 2025 | $31.02 |
| Oct 06, 2025 | $31.65 |
| Oct 07, 2025 | $26.15 |
| Oct 08, 2025 | $25.85 |
| Oct 09, 2025 | $25.15 |
| Oct 10, 2025 | $23.49 |
| 4 days before | 5.11% |
| 4 days after | -25.78% |
| On release day | -17.38% |
| Change in period | -21.99% |
| Release date | Jan 08, 2026 |
| Price on release | $22.70 |
| EPS estimate | -$0.0800 |
| EPS actual | -$0.0400 |
| EPS surprise | 50.00% |
| Date | Price |
|---|---|
| Jan 02, 2026 | $22.16 |
| Jan 05, 2026 | $23.49 |
| Jan 06, 2026 | $24.73 |
| Jan 07, 2026 | $24.18 |
| Jan 08, 2026 | $22.70 |
| Jan 09, 2026 | $26.32 |
| Jan 12, 2026 | $26.35 |
| Jan 13, 2026 | $26.81 |
| Jan 14, 2026 | $25.97 |
| 4 days before | 2.44% |
| 4 days after | 14.41% |
| On release day | 15.95% |
| Change in period | 17.19% |
| Release date | Apr 07, 2026 |
| Price on release | $50.25 |
| EPS estimate | -$0.0800 |
| EPS actual | -$0.0500 |
| EPS surprise | 37.50% |
| Date | Price |
|---|---|
| Mar 31, 2026 | $37.08 |
| Apr 01, 2026 | $39.60 |
| Apr 02, 2026 | $44.32 |
| Apr 06, 2026 | $52.16 |
| Apr 07, 2026 | $50.25 |
| Apr 08, 2026 | $63.16 |
| Apr 09, 2026 | $68.86 |
| Apr 10, 2026 | $70.43 |
| Apr 13, 2026 | $71.66 |
| 4 days before | 35.52% |
| 4 days after | 42.61% |
| On release day | 25.69% |
| Change in period | 93.26% |
| Release date | Jul 14, 2026 |
| Price on release | - |
| EPS estimate | -$0.0100 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 12, 2026 | $108.47 |
| Jun 15, 2026 | $115.88 |
| Jun 16, 2026 | $104.83 |
| Jun 17, 2026 | $112.62 |
| Jun 18, 2026 | $115.30 |
Aehr Test Systems Earnings Call Transcript Summary of Q1 2026
Aehr Test Systems reported a stronger-than-expected start to fiscal 2026 with Q1 revenue of $11.0 million, beating analyst consensus, and gross momentum across multiple markets driven largely by AI-related demand. Management highlighted accelerating customer engagement for package-level (Sonoma) and wafer-level (FOX XP) test and burn-in solutions — including multiple follow-on orders and shorter lead-time requests from a leading hyperscaler — and a paid evaluation program with a top-tier AI processor supplier for 300 mm wafer-level burn-in. The company emphasized its unique positioning as a vendor offering both wafer-level and packaged-part burn-in, recent product enhancements (higher power per device, increased parallelism, full automation for Sonoma), and strengthened manufacturing capacity following a completed facility renovation (management estimates manufacturing capacity increased by at least ~5x). Q1 consumables/contact revenue was $2.6 million (24% of sales), lower than the prior-year quarter which had unusually high consumables, contributing to a non-GAAP gross margin decline to 37.5% from 54.7% a year earlier. Operating expenses rose modestly due to R&D and consolidation costs; the company recorded a one-time restructuring charge of $219k. Backlog was $15.5 million at quarter end (management noted bookings in the early weeks of the new quarter), cash and equivalents totaled $24.7 million, and the company has no debt. Management remains cautious and is not reinstating formal guidance due to tariff uncertainty, but reiterated confidence in broad-based growth across AI, silicon photonics, GaN, SiC, HDD, and flash/HBF opportunities.
Sign In
Buy AEHR